usnic acid has been researched along with Carcinoma, Hepatocellular in 4 studies
Carcinoma, Hepatocellular: A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sorafenib (SOR) is an orally administered molecular targeted agent in the systemic chemotherapy of hepatocellular carcinoma (HCC)." | 7.91 | Investigation of new treatment option for hepatocellular carcinoma: a combination of sorafenib with usnic acid. ( Cecener, G; Egeli, U; Eryilmaz, IE; Guney Eskiler, G; Tunca, B; Yurdacan, B, 2019) |
| "Usnic acid (UA) is a multifunctional bioactive lichen secondary metabolite with potential anti-cancer properties." | 5.51 | The role of usnic acid-induced apoptosis and autophagy in hepatocellular carcinoma. ( Cecener, G; Egeli, U; Eryilmaz, IE; Eskiler, GG; Tunca, B; Yurdacan, B, 2019) |
| "Sorafenib (SOR) is an orally administered molecular targeted agent in the systemic chemotherapy of hepatocellular carcinoma (HCC)." | 3.91 | Investigation of new treatment option for hepatocellular carcinoma: a combination of sorafenib with usnic acid. ( Cecener, G; Egeli, U; Eryilmaz, IE; Guney Eskiler, G; Tunca, B; Yurdacan, B, 2019) |
| "Usnic acid (UA) is a multifunctional bioactive lichen secondary metabolite with potential anti-cancer properties." | 1.51 | The role of usnic acid-induced apoptosis and autophagy in hepatocellular carcinoma. ( Cecener, G; Egeli, U; Eryilmaz, IE; Eskiler, GG; Tunca, B; Yurdacan, B, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, Y | 1 |
| Yan, Y | 1 |
| Huo, Y | 1 |
| Pang, Y | 1 |
| Chan, L | 1 |
| Wang, S | 1 |
| Chen, D | 1 |
| Lin, D | 1 |
| Wang, W | 1 |
| Yurdacan, B | 2 |
| Egeli, U | 2 |
| Eskiler, GG | 1 |
| Eryilmaz, IE | 2 |
| Cecener, G | 2 |
| Tunca, B | 2 |
| Guney Eskiler, G | 1 |
| Su, ZQ | 1 |
| Liu, YH | 1 |
| Guo, HZ | 1 |
| Sun, CY | 1 |
| Xie, JH | 1 |
| Li, YC | 1 |
| Chen, JN | 1 |
| Lai, XP | 1 |
| Su, ZR | 1 |
| Chen, HM | 1 |
4 other studies available for usnic acid and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
mRNA sequencing and CyTOF analysis revealed ASPP2 altered the response patterns of hepatocellular carcinoma HepG2 cells to usnic acid.
Topics: Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Hep G2 Cells; Humans; Li | 2023 |
The role of usnic acid-induced apoptosis and autophagy in hepatocellular carcinoma.
Topics: Antineoplastic Agents; Apoptosis; Autophagy; Benzofurans; Carcinoma, Hepatocellular; Cell Cycle Chec | 2019 |
Investigation of new treatment option for hepatocellular carcinoma: a combination of sorafenib with usnic acid.
Topics: Annexin A5; Antineoplastic Agents; Apoptosis; Benzofurans; Carcinoma, Hepatocellular; Cell Line, Tum | 2019 |
Effect-enhancing and toxicity-reducing activity of usnic acid in ascitic tumor-bearing mice treated with bleomycin.
Topics: Adjuvants, Pharmaceutic; Animals; Antineoplastic Agents; Apoptosis; Ascites; Benzofurans; Bleomycin; | 2017 |